CSL : Seqirus to Present at 9th ESWI Conference on the Burden of Influenza and Impact of Vaccination on Public Health -September 15, 2023 at 08:39 am EDT

CSL Seqirus to Present at 9th ESWI Conference on the Burden of Influenza and Impact of Vaccination on Public Health



SUMMIT, N.J., September 15, 2023 --...

Related Keywords

Australia ,France ,Spain ,Valencia ,Carabobo ,Venezuela ,Belgium ,New Jersey ,United States ,Belgian ,Raja Rajaram ,European Medicines Agency ,World Health Organization ,European Scientific Working Group On Influenza ,Development Of Self ,Twitter ,Centers For Disease ,European Scientific Working Group ,Global Medical Strategy ,Young Scientist Vaccine Innovation Award ,Poster Presentations ,Cross Reactive ,Improved Safety ,High Dose Trivalent Influenza Vaccine ,High Risk ,Influenza Complications ,Poor Immune Response During ,Influenza Vaccination ,Bed Usage ,Influenza Season Under Endemic ,Adjuvanted Quadrivalent Influenza Vaccine ,Belgian Elderly ,Anti Neuraminidase Antibody Responses ,Hemisphere Season ,Combination Vaccines ,Zoonotic Influenza Surveillance ,Vital Component ,Rapid Pandemic ,Resource Use ,Complications Among Adults ,Influenza Related Medical Encounter ,Global Overview Based ,Net Database ,Disease Control ,Adjuvanted Influenza Vaccine ,High Dose Influenza Vaccine ,Older Adults ,Influenza Risk Factors ,Key Facts ,Accessed September ,Estimated Influenza Illnesses ,Who Needs ,Key Facts About Influenza ,Health Organization ,Pandemic Influenza Risk Management ,Medicines Agency ,Markets ,